RxDoctor Payments Data

Jessica Barr, PA

Medical · Aurora, CONPI 1780067629

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Medtronic at 40.9% of the total. Among medical clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,784in general payments, 2019–2025

Across 58 payments — averaging $151.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Neurocrine Biosciences, Inc.$3K
  • AbbVie$2K
  • Merz Pharmaceuticals, LLC$317
  • Boston Scientific$155
  • Mentor Worldwide LLC$55

What the payments were for

  • Consulting fees$3,55040%
  • Travel & lodging$2,02123%
  • Food & beverage$3,21237%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,784 in reported general payments places this provider in the 95th percentile of 766 medical providers in Colorado.

See all medical providers in Colorado

Medicare billing

Part B allowed, 2024
$80,916
Medicare patients
375
Services billed
831

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RytaryCarbidopa/Levodopa303$700,418
NeuproRotigotine40$93,244
NuplazidPimavanserin Tartrate12$60,328
NourianzIstradefylline12$40,255
Carbidopa-LevodopaCarbidopa/Levodopa719$37,852
Rasagiline Mesylate88$21,790
Entacapone53$18,142
Carbidopa-Levodopa ErCarbidopa/Levodopa322$13,918
Selegiline Hcl100$13,619
MyrbetriqMirabegron16$13,413
Rivastigmine46$10,750
RivastigmineRivastigmine Tartrate95$7,971
Carbidopa20$6,797
AmantadineAmantadine Hcl86$5,138
Venlafaxine Hcl ErVenlafaxine Hcl50$4,561

Paid to pharmacies, not to this prescriber.

Other medical in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →